Skip to content
  • +44 (0) 1302 986 088
  • [email protected]
  • ISO/IEC 17025:2017
Twitter Instagram Facebook-f Linkedin-in
  • About
    • Damien Bove
  • Services
    • Regulatory compliance
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Analytical testing
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Support resources
      • tpd.expert
        • Disposables checklist
        • Shortfills checklist
        • Nicotine Range Checklist
      • TPD by Country
      • Vape Safe
  • CBD
  • TPD
  • Herbals
  • News
  • Calendar
  • Contact
Menu
  • About
    • Damien Bove
  • Services
    • Regulatory compliance
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Analytical testing
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Support resources
      • tpd.expert
        • Disposables checklist
        • Shortfills checklist
        • Nicotine Range Checklist
      • TPD by Country
      • Vape Safe
  • CBD
  • TPD
  • Herbals
  • News
  • Calendar
  • Contact
£0.00 0 Basket
  • Login
  • Register
  • Track my order
Twitter Instagram Facebook-f Linkedin-in
£0.00 0 Basket
  • Login
  • Register
  • Track my order
  • About
    • Damien Bove
  • Services
    • Regulatory compliance
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Analytical testing
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Support resources
      • tpd.expert
        • Disposables checklist
        • Shortfills checklist
        • Nicotine Range Checklist
      • TPD by Country
      • Vape Safe
  • CBD
  • TPD
  • Herbals
  • News
  • Calendar
  • Contact
Menu
  • About
    • Damien Bove
  • Services
    • Regulatory compliance
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Analytical testing
      • Cannabinoid (CBD)
      • TPD
      • Herbals
    • Support resources
      • tpd.expert
        • Disposables checklist
        • Shortfills checklist
        • Nicotine Range Checklist
      • TPD by Country
      • Vape Safe
  • CBD
  • TPD
  • Herbals
  • News
  • Calendar
  • Contact

New PMTA uncertainty

New PMTA uncertainty

The U.S. Food and Drug Administration (FDA) displayed the final rule for the Premarket Tobacco Product Application (PMTA) in the federal register, but it did not get published on 19 January 2021.

A day later on 20 January, a memo from The White House Chief of Staff ordered the withdrawal of any rules that did not publish in the federal register on that day, therefore this final rule has been withdrawn at the current time.

This means that once again the electronic cigarette and vaping industry in the US is in limbo, applying for PMTA approval with no published final rule available.

ADACT’s Chief Regulatory Officer, Damien Bové, said “This raises two key questions — Will the new administration ask for changes to the rules for affected products? Will this affect any applications which have already filed? The situation is still developing so please check ADACT’s social media channels for updates.”

To book a meeting about PMTA, please call ADACT on +44(0)1302 986 088 or email [email protected]

Share:

More Posts

ADACT Vape Safe

ADACT’s Vape Safe Disposable Certification Programme

With the current crisis that has gripped the vape market

Belgium’s proposed new regulations

ADACT have been informed of a range of new regulations

Damien Bové interviewed by CBD publication

Damien Bové interviewed by CBD publication

ADACT Medical’s Chief Regulatory Officer, Damien Bové, was recently interviewed

Merry Christmas from ADACT

Merry Christmas from ADACT

A truly big thank you from all of us at

NextTake part in a new public consultationNext

Related News

ADACT’s Vape Safe Disposable Certification Programme
February 7, 2023

ADACT’s Vape Safe Disposable Certification Programme

With the current crisis that has gripped the vape market with regard to

More details
Belgium’s proposed new regulations
January 18, 2023

Belgium’s proposed new regulations

ADACT have been informed of a range of new regulations which are are

More details
Damien Bové interviewed by CBD publication
December 7, 2022

Damien Bové interviewed by CBD publication

ADACT Medical’s Chief Regulatory Officer, Damien Bové, was recently interviewed by respected publication

More details
ADACT leading regulatory compliance specialists with cutting edge analytical testing.

Services

  • Regulatory compliance
  • Analytical testing
  • Support resources
  • Regulatory compliance
  • Analytical testing
  • Support resources

Company

  • About
  • Contact
  • News
  • Calendar
  • About
  • Contact
  • News
  • Calendar

Others

  • Login
  • Register
  • Track my order
  • Login
  • Register
  • Track my order

GDPR

  • Privacy settings page
  • Terms & conditions
  • Privacy policy
  • Shipping policy
  • Privacy settings page
  • Terms & conditions
  • Privacy policy
  • Shipping policy

Copyright © ADACT Medical Ltd 2022 All rights reserved. Registered in England & Wales Company No: 08173910